Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: A positron emission tomography study

Neuropsychopharmacology

Volumn 15, Issue 3, 1996, Pages 302-313

  Gillin, J Christian ^b   Buchsbaum, Monte S ^c   Valladares Neto, Dirceu C ^c   Hong, Charles Chong Hwa ^c   Hazlett, Erin ^c   Langer, Salomon Z ^a   Wu, Joseph ^c  

^a SANOFI   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Benzodiazepine receptor subtype; Cerebral metabolism; FDG; Imidazopyridine; Insomnia; Omega1 receptor; PET

Indexed keywords

GLUCOSE; ZOLPIDEM;

ARTICLE; BRAIN METABOLISM; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SLEEP;

EID: 0030250048     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00234-5     Document Type: Article

References (53)

1. Avery DH, Wildschiodtz G, Smallwood RG, Martin D, Rafaelson OJ (1986): REM latency and core temperature relationships in primary depression. Acta Psychiatr Scand 74:269-280
2. Bartlett EJ, Barouche F, Brodie JD, Wolkin A, Angrist B, Rotrosen J, Wolf AP (1991): Stability of resting deoxyglucose metabolic values in PET studies in schizophrenia. Psychiatry Res Neuroimag 40:11-22
3. Benavides J, Peny B, Durand A, Arbilla S, Scatton B (1993a): Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H] flumazenil binding in the rat central nervous system. J Pharmacol Exp Ther 263:884-896
4. Benavides J, Peny B, Ruano D, Victorica J, Scatton B (1993b): Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 604:240-250
5. Blois R, Gaillard JM (1988): The effects of zolpidem on characteristics of normal human sleep. In Sauvanet JP, Langer SZ, Morselli PL (eds), Imidazopyridines in Sleep Disorders. New York, Raven, pp. 375-376
6. Bonnet MH, Arand DL (1992): Caffeine use as a model of acute and chronic insomnia. Sleep 15:526-536
7. Bonnet MH, Berry RB, Arand DL (1991): Metabolism during normal, fragmented, and recovery sleep. J Appl Physiol 71:1112-1118
8. Boyle PJ, Scott JC, Krentz AJ, Nagy RJ, Comstack E, Hoffman C (1994): Diminished brain glucose metabolism is a sufficient determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 93:529-535
9. Brunner DP, Dijk D-J, Münch M, Borbély AA (1991): Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology 104:1-5
10. Buchsbaum MS, Delisi LE, Holcomb H, Capelletti J, King AC, Johnson J, Hazlett E, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Kessler R (1984): Anterior-posterior gradients in cerebral glucose metabolism use in schizophrenia and affective disorders. Arch Gen Psychiatry 41:1159-1166
11. Buchsbaum MS, Wu JC, Haier RJ, Hazlett E, Ball R, Katz M, Sokolski K, Lagunas-Solar M, Langer DH (1987): Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci 40:2393-2400
12. Buchsbaum MS, Gillin JC, Wu J, Hazlett E, Sicotte N, Dupont RM (1989): Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci 45:1349-1356
13. Buchsbaum MS, Potkin S, Marshall J, Lottenberg S, Teng CY, Heh CW, Tafalla R, Reynolds C, Abel L, Plon L, Bunney WE (1992a): Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology 6:155-163
14. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, Marshall JF, Lottenberg S, Tang CY, Abel L, Plon L, Bunney WE (1992b): Striatal Metabolic Rate and Clinical Response to Neuroleptics in Schizophrenia. Arch Gen Psychiatry 49:966-974
15. Copinschi G, Akseli E, Moreno-Reyes R, Leproult R, L'Hermite-Balériauz M, Caufriez A, Vertongen F, and Van Cauter E (1995): Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep 18:417-424
16. de Wit H, Metz J, Wagner N, Cooper M (1991): Effects of diazepam on cerebral metabolism and mood in normal volunteers. Neuropsychopharmacology 5:33-41
17. Fairweather DB, Kerr JS, Hindmarch I (1992): The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 43:597-601
18. Foster NL, Van Der Spek AF, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW (1987): The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J Cereb Blood Flow Metab 7:415-420
19. Franzini C (1992): Brain metabolism and blood flow during sleep. J Sleep Res 1:3-16
20. Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thénot JP, Morselli PL (1989): Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248:1283-1288
21. Gillin JC, Mendelson WB (1980): Sleeping pills. For whom? When? How Long? In Palmer GC (ed), Neuropharmacology of Central Nervous System and Behavioral Disorders. New York, Academic Press, pp. 285-316
22. Guinebault P, et al. (1986): High performance liquid chromatography determination of zolpidem, a new sleep inducer, in biological fluids with fluommetric detection. J Chromatogr 383:206-211
23. Harris GJ, Links JM, Pearlson GD, Camargo EE (1991): Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease. Psych Res Neuroimag 40:167-180
24. Home JA, Shackell BS (1987): Slow wave sleep after body heating: Proximity to sleep and effects of aspirin. Sleep 10:383-392
25. Jonas JM, Coleman BS, Sheridan AQ, Kalinske RW (1992): Comparative clinical profiles of triazolam versus other shorter-acting hypnotics. J Clin Psychiatry 53(suppl):19-33
26. Kennedy C, Gillin JC, Mendelson WB, et al. (1982): Local cerebral glucose utilization in Non-REM sleep. Nature 297:325-327
27. Langer SZ, Arbilla S (1988): Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes. Pharmacol Biochem Behav 29(4):763-766
28. Lund R, Rüther E, Wober W, Hippius H (1988): Effects of zolpidem (10 and 20 mg), lorazepam, triazolam and placebo on night sleep and residual effects during the day. In Sauvanet JP, Langer SZ, Morselli PL (eds), Imidazopyridines in Sleep Disorders. New York, Raven, pp 193-204
29. Maarek L, Cramer P, Attali P, Coquelin JP, Morselli PL (1992): The safety and efficacy of zolpidem in insomniac patients: A long-term open study in general practice. J Int Med Res 20(2):162-170
30. McGinty D, Szymusiak R (1990): Keeping cool: A hypothesis about the mechanisms and functions of slow wave sleep. Trends Neurosci 13:480-487
31. Madsen P, Vorstrup S (1991a): Cerebral blood flow and metabolism during sleep. Cerebrovasc Brain Metab Rev 3:281-296
32. 2 metabolism and cerebral blood flow in humans during sleep and rapid-eye-movement sleep. J Appl Physiol 80:2597-2601
33. 2-subunit in situ. J Recept Res 13(1-4):467-477
34. Maquet P, Dive D, Salmon E, et al. (1992): Cerebral glucose utilization during stage 2 sleep in man. Brain Res 571:149-153
35. Maziere B, Maziere M (1990): Where have we gone to with neuroreceptor mapping of the human brain? Eur J Nuc Med 16:817-835
36. Merlotti L, Rochrs T, Koshorek G, Zorick F, Lamphere J, Roth T (1989): The dose effects of zolpidem on the sleep of healthy normals. J Clin Pharmacol 1:9-14
37. 5- and delta-subunit-specific immunopurification. J Biol Chem 268 (8):5965-5973
38. Monroe LJ (1967): Psychological and physiological differences between good and bad sleepers. J Abnorm Psychol 72:255-264
39. Nakamura R, Kennedy C, Gillin JC, et al. (1983): Hypnogenic center theory of sleep: No support from metabolic mapping in monkeys. Brain Res 268:372-376
40. Nicholson AN, Pascoe PA (1986): Hypnotic activity of an imidazolpyridine (zolpidem). Brit J Clin Pharmacol 21:205-211
41. Piercey MF, Hoffman WE, Cooper M (1991): The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: Implications for benzodiazepine receptor subtypes. Brain Res 554(1-2):244-252
42. Ramm P, Frost BJ (1983): Regional activity in rat brain during sleep wake activity. Sleep 6:196-216
43. Ramm P, Frost BJ (1986): Cerebral and local glucose cerebral metabolism in the cat during slow wave and REM sleep. Brain Res 365:112-124
44. Rechtschaffen A, Kales A (1971): A manual of standard techniques and scoring system for sleep stages in human subjects. Washington, DC, Superintendent of Documents, U.S. Government Printing Office
45. Roger M. Attali P, Coguelin JP (1993): Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther 15(1):127-136
46. Ruano D, Benavides J, Machado A, Victorica J (1993): Regional differences in the enhancement of GABA of [3H] zolpidem binding to omega 1 sites in rat brain membranes and sections. Brain Res 600(1):134-140
47. Scharf MB (1991): Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 52:77-83
48. Shaw SH, Curson H, Coquelin JP (1992): A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric patients. Neuropsychopharmacology 7(1):1-5
49. Thénot JP, Hermann P, Durand A, Burke JJ, Allen J, Garrigou D, Vajta S, Albin H, Thébault JJ, Olive E, Warrington SJ (1988): Pharmacokinetics and metabolism of zolpidem in various animal species and in humans. In Sauvanet JP, Langer SZ, Morselli PL (eds), Imidazopyridines in Sleep Disorders. New York, Raven, pp 139-153
50. Wafford KA, Whiting PJ, Kemp JA (1993): Differences in affinity and efficacy of benzodiazepine receptor ligands are recombinant gamma-aminobutyric acid A receptor subtypes. Mol Pharmacol 43(2):240-244
51. Wu JC, Gillin JC, Buchsbaum MS, Hazlett E, Sicotte N, Bunney WE Jr (1991a): The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep 14:155-162
52. Wu JC, Buchsbaum MS, Hershey TG, Hazlett E, Sicotte N (1991b): PET in generalized anxiety disorder. Biol Psychiatry 29:1181-1199
53. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE (1992): Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149: 538-543